Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways
Data up to Jan 2025
Total Citations Per Year
Abstract
References (43)
Mdm2 promotes the rapid degradation of p53
1997 • 4,336 citations
Regulation of p53 stability by Mdm2
1997 • 3,238 citations
The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product
1989 • 3,036 citations
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
1990 • 2,587 citations
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
1993 • 2,329 citations
Tumor spectrum analysis in p53-mutant mice
1994 • 2,034 citations
Testing Statistical Hypotheses
1986 • 1,765 citations
Papillomavirus infections — a major cause of human cancers
1996 • 1,536 citations
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
1989 • 1,345 citations
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
1989 • 1,186 citations
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
1995 • 1,114 citations
Testing Statistical Hypotheses.
1988 • 996 citations
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
1996 • 904 citations
The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A
1988 • 657 citations
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
1992 • 617 citations
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
1993 • 526 citations
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
1997 • 506 citations
p53 in growth control and neoplasia
1996 • 488 citations
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
1997 • 461 citations
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
1994 • 347 citations
Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.
1992 • 327 citations
Comparison of the in vitro transforming activities of human papillomavirus types.
1988 • 303 citations
Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene
1996 • 264 citations
Destabilization of the RB Tumor Suppressor Protein and Stabilization of p53 Contribute to HPV Type 16 E7-Induced Apoptosis
1997 • 260 citations
Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma
1989 • 247 citations
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
1994 • 243 citations
Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development.
1995 • 234 citations
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein
1997 • 183 citations
Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells
1989 • 171 citations
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation
1996 • 126 citations
Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation
1993 • 126 citations
The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints
1997 • 121 citations
Cellular transformation by papilomavirus oncorproteins
1993 • 77 citations
Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs.
1993 • 74 citations
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity
1992 • 72 citations
Mutational Analysis of Human Papillomavirus Type 16 E6 Protein: Transforming Function for Human Cells and Degradation of p53 in Vitro
1995 • 65 citations
Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity
1997 • 64 citations
Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells.
1993 • 63 citations
Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice
1997 • 59 citations
Perturbation of the p53 response by human papillomavirus type 16 E7
1997 • 44 citations
Nonradioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy.
1991 • 40 citations
Degradation of p53 only is not sufficient for the growth stimulatory effect of human papillomavirus 16 E6 oncoprotein in human embryonic fibroblasts
1994 • 19 citations
E6 and E7 expression from the HPV 18 LCR: development of genital hyperplasia and neoplasia in transgenic mice.
1995 • 17 citations
Cited By (0)
No citing papers found in database